Medicenna to Announce First Quarter Fiscal 2022 Financial Results and Operational Highlights on Friday, August 13, 2021

NEXT STORY
Enzyvant Announces Publication of Positive Clinical Data in Pediatric Patients with Congenital Athymia Treated with Investigational RVT-802 (allogeneic processed thymus tissue-agdc)
PREV STORY
Global Nucleic Acid Isolation and Purification Markets 2021-2031: Emergence of Advanced Stabilization Products / Regulated vs. Multimodal / Novel Targets / New Applications
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New Study with Abiomed’s Impella 2.5® Heart Pump Demonstrates Potential Survival with Pre-PCI Insertion in Heart Attacks with the Left Main Coronary Artery

DANVERS, Mass., June 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider ...

author_avatar
NASDAQ Market News

Generic Pharmaceuticals Market Sees North America Accounting For Almost 50% Of The Total Share As Per The Business Research Company’s Generic Pharmaceuticals Global Market Report 2021

author_avatar
NASDAQ Market News

RedHill Biopharma Announces Publication of Talicia® Pivotal Phase 3 Study Results in Annals of Internal Medicine

author_avatar
NASDAQ Market News